Latham & Watkins Represents Omada Health in IPO

Omada Health, the virtual between-visit healthcare provider, has announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a public offering price of US$19.00 per share. In addition, Omada Health has granted the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on June 6, 2025, under the ticker symbol “OMDA.” The offering is expected to close on June 9, 2025, subject to customary closing conditions.

Latham & Watkins LLP represents Omada Health in the offering with a corporate deal team led by Bay Area partners Kathleen Wells and Richard Kim, with associates Josh Landis, Jacob Kempf, Ryleigh Chen, and Keran Huang. Advice was also provided on regulatory matters by Washington, D.C. partner Ben Haas and Bay Area partner Betty Pang, with associate Meryl Bartlett; on benefits matters by Bay Area partner Ashley Wagner and Chicago counsel Sandhya Chandrasekhar, with associate Megan Ampe; on data privacy matters by Bay Area partner Heather Deixler; on intellectual property matters by Bay Area counsel Arielle Singh, with associate Caroline Omotayo; and on tax matters by Bay Area partner Grace Lee, with associate Rasha Suleiman.